DOTS-Plus and Green Light Committee
This booklet explains the relationship between MDR-TB, DOTS, and DOTS-Plus and how projects can become a DOTS-Plus pilot project that can benefit from concessionary prices negotiated for second-line anti-TB drugs by the Working Group.
Author:
World Health Organization
Audiences:
Managers and Supervisors
Topic:
MDR TB, Partnership Building, Treatment- Directly Observed Therapy (DOT)
Global resources for the prevention,
management, and elimination of TB.